Role of neoadjuvant therapy for nonmetastatic pancreatic cancer: Current evidence and future perspectives

Pancreatic adenocarcinoma (PDAC) is one of the most common and lethal human cancers worldwide. Surgery followed by adjuvant chemotherapy offers the best chance of a long-term survival for patients with PDAC, although only approximately 20% of the patients have resectable tumors when diagnosed. Neoad...

Descripción completa

Detalles Bibliográficos
Autores principales: Cassese, Gianluca, Han, Ho-Seong, Yoon, Yoo-Seok, Lee, Jun Suh, Lee, Boram, Cubisino, Antonio, Panaro, Fabrizio, Troisi, Roberto Ivan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302990/
https://www.ncbi.nlm.nih.gov/pubmed/37389109
http://dx.doi.org/10.4251/wjgo.v15.i6.911

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302990/
https://www.ncbi.nlm.nih.gov/pubmed/37389109
http://dx.doi.org/10.4251/wjgo.v15.i6.911

Ejemplares similares